358 related articles for article (PubMed ID: 10796739)
1. Cernilton for benign prostatic hyperplasia.
Wilt T; Mac Donald R; Ishani A; Rutks I; Stark G
Cochrane Database Syst Rev; 2000; (2):CD001042. PubMed ID: 10796739
[TBL] [Abstract][Full Text] [Related]
2. WITHDRAWN: Cernilton for benign prostatic hyperplasia.
Wilt TJ; Macdonald R; Ishani A; Rutks I; Stark G
Cochrane Database Syst Rev; 2011 May; 2011(5):CD001042. PubMed ID: 21563128
[TBL] [Abstract][Full Text] [Related]
3. Serenoa repens for benign prostatic hyperplasia.
Wilt T; Ishani A; Mac Donald R
Cochrane Database Syst Rev; 2002; (3):CD001423. PubMed ID: 12137626
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of Cernilton for the treatment of benign prostatic hyperplasia.
MacDonald R; Ishani A; Rutks I; Wilt TJ
BJU Int; 2000 May; 85(7):836-41. PubMed ID: 10792162
[TBL] [Abstract][Full Text] [Related]
5. Pygeum africanum for benign prostatic hyperplasia.
Wilt T; Ishani A; Mac Donald R; Rutks I; Stark G
Cochrane Database Syst Rev; 2002; 1998(1):CD001044. PubMed ID: 11869585
[TBL] [Abstract][Full Text] [Related]
6. Serenoa repens for benign prostatic hyperplasia.
Wilt T; Ishani A; Stark G; MacDonald R; Mulrow C; Lau J
Cochrane Database Syst Rev; 2000; (2):CD001423. PubMed ID: 10796790
[TBL] [Abstract][Full Text] [Related]
7. Serenoa repens for benign prostatic hyperplasia.
Tacklind J; MacDonald R; Rutks I; Wilt TJ
Cochrane Database Syst Rev; 2009 Apr; (2):CD001423. PubMed ID: 19370565
[TBL] [Abstract][Full Text] [Related]
8. Tamsulosin for benign prostatic hyperplasia.
Wilt TJ; Mac Donald R; Rutks I
Cochrane Database Syst Rev; 2003; (1):CD002081. PubMed ID: 12535426
[TBL] [Abstract][Full Text] [Related]
9. Phytotherapy for benign prostatic hyperplasia.
Wilt TJ; Ishani A; Rutks I; MacDonald R
Public Health Nutr; 2000 Dec; 3(4A):459-72. PubMed ID: 11276294
[TBL] [Abstract][Full Text] [Related]
10. Serenoa repens for benign prostatic hyperplasia.
Tacklind J; Macdonald R; Rutks I; Stanke JU; Wilt TJ
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD001423. PubMed ID: 23235581
[TBL] [Abstract][Full Text] [Related]
11. WITHDRAWN: Tamsulosin for benign prostatic hyperplasia.
Wilt TJ; Macdonald R; Rutks I
Cochrane Database Syst Rev; 2011 Sep; 2011(9):CD002081. PubMed ID: 21901681
[TBL] [Abstract][Full Text] [Related]
12. Beta-sitosterols for benign prostatic hyperplasia.
Wilt T; Ishani A; MacDonald R; Stark G; Mulrow C; Lau J
Cochrane Database Syst Rev; 2000; 1999(2):CD001043. PubMed ID: 10796740
[TBL] [Abstract][Full Text] [Related]
13. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review.
Wilt TJ; Ishani A; Stark G; MacDonald R; Lau J; Mulrow C
JAMA; 1998 Nov; 280(18):1604-9. PubMed ID: 9820264
[TBL] [Abstract][Full Text] [Related]
14. Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement.
Franco JV; Trivisonno L; Sgarbossa NJ; Alvez GA; Fieiras C; Escobar Liquitay CM; Jung JH
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD001423. PubMed ID: 37345871
[TBL] [Abstract][Full Text] [Related]
15. Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis.
Ishani A; MacDonald R; Nelson D; Rutks I; Wilt TJ
Am J Med; 2000 Dec; 109(8):654-64. PubMed ID: 11099686
[TBL] [Abstract][Full Text] [Related]
16. Terazosin for benign prostatic hyperplasia.
Wilt TJ; Howe RW; Rutks IR; MacDonald R
Cochrane Database Syst Rev; 2002; (4):CD003851. PubMed ID: 12519611
[TBL] [Abstract][Full Text] [Related]
17. Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review.
MacDonald R; Tacklind JW; Rutks I; Wilt TJ
BJU Int; 2012 Jun; 109(12):1756-61. PubMed ID: 22551330
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia.
Pattanaik S; Mavuduru RS; Panda A; Mathew JL; Agarwal MM; Hwang EC; Lyon JA; Singh SK; Mandal AK
BJU Int; 2019 Jul; 124(1):27-34. PubMed ID: 30681264
[TBL] [Abstract][Full Text] [Related]
19. WITHDRAWN: Terazosin for benign prostatic hyperplasia.
Wilt TJ; Howe RW; Rutks I; Macdonald R
Cochrane Database Syst Rev; 2011 Sep; 2011(9):CD003851. PubMed ID: 21901686
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of Cernilton in the treatment of benign prostatic hyperplasia.
Dutkiewicz S
Int Urol Nephrol; 1996; 28(1):49-53. PubMed ID: 8738619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
